REFERENCES
- T. Arakawa, and S. N. Timsheff. (1992). Stabilization of protein structure by sugars. Biochemistry 21:6536–6544.
- J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. Liu, B. Pulendran, and K. Palucka. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 8:767–811.
- D. T. Brandau, L. S. Jones, C. M. Wiefthoff, J. Rexroad, and C. R. Middaugh. (2003). Thermal stability of vaccines. J. Pharm. Sci. 92 (2):218–231.
- F. R. Brennan, and G. Dougan. (2005). Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine 23:3210–3222.
- J. F. Carpenter, J. H. Crowe, and T. Arakawa. (1986). Comparison of solute-induced protein stabilization in aqueous solution and in the frozen and dried states. J. Dairy Sci. 73:3627–3636.
- B. G. Davis, and M. A. Robinson. (2002). Drug delivery systems based on sugar-macromolecule conjugates. Curr. Opin. Drug Discov. Devel. 5 (2):279–288.
- A. K. Goyal, A. Rawat, S. Mahor, P. N. Gupta, K. Khatri, and S. P. Vyas. (2006). Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation. Int. J. Pharm. 309:227–233.
- P. N. Gupta, V. Mishra, A. Rawat, P. Dubey, S. Mahor, S. Jain, D. P. Chatterji, and S. P. Vyas. (2005). Noninvasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm. 293:73–82.
- R. K. Gupta, and G. R. Siber. (1995). Adjuvants for human vaccines: current status, problems and future prospects. Vaccine 13:1263–1276.
- R. H. M. Hatley, and J. A. Blair. (1999). Stabilisation and delivery of labile materials by amorphous carbohydrates and their derivatives. J. Mol. Catal., B Enzym. 7:11–19.
- Q. He, A. R. Mitchell, S. L. Johnson, C. W. Bartak, T. Morcol, and S. J. D. Bell. (2000). Calcium phosphate nanoparticle adjuvant. Clin. Diagn. Lab. Immunol. 7 (6):899–903.
- V. L. Hegde, and Y. P. Venkatesh. (2007). Generation of antibodies specific to D-mannitol, a unique haptenic allergen, using reductively aminated D-mannose–bovine serum albumin conjugate as the immunogen. Immunobiology 212:119–128.
- M. R. Hillman. (2002). Overview of the needs and realities for developing new and improved vaccines in the 21st Century. Intervirology 45:199–211.
- R.-O. Irma, S.-L. A. Rodrigo, R.-G. Jose, and Q.-B. T. Carlos. (2007). Elaboration and structural analysis of aquasomes loaded with indomethacin. Eur. J. Pharm. Sci. 32 (3):223–230.
- K. S. Jaganathan, and S. P. Vyas. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 24 (19):4201–4211.
- A. J. Khopade, S. Khopade, and N. K. Jain. (2002). Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer. Int. J. Pharm. 241 (1):145–154.
- N. Kossovsky, A. Gelman, J. Hnatyszyn, E. Sponsler, and G. M. Chow. (1995). Conformationally stabilizing self-assembling nanostructured delivery vehicle for biochemically reactive pairs. Nano Struct. Mater. 5 (2):233–247.
- N. Kossovsky, E. Sponsler, and H. J. Hnatyszyn. (1993). Self-Assembling nanostructures. Biotechnology 11:1534–1536.
- U. K. Laemmli. (1970). Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227:680–685.
- D. J. M. Lewis. (1996). Design and production of single-immunization vaccines using poly-(lactic)-co-(glycolic) acid microsphere systems. In A. Robinsons, G. H. Farrer, and C. N. Wiblin. Methods in molecular medicine: Vaccine protocols. 140–147. New Jersey: Humana Press.
- M. F. Mazzobre, and M. P. Buera. (1999). Combined effects of trehalose and cations on the thermal resistance of b-galactosidase in freeze dried systems. Biochimica Biophys. Acta 1473:337–344.
- R. A. Merz, M. Horsch, H. P. Ruffner, and D. M. Rast. (1999). Interaction between chitosan and concanavalin A. Phytochemistr 52:211–224.
- D. P. Miller, J. dePablo, and H. R. Corti. (1997). Thermophysical properties of trehalose and its concentrated aqueous solutions. Pharm. Res. 14:578–589.
- V. Mishra, S. Mahor, A. Rawat, P. Dubey, P. N. Gupta, P. Singh, and S. P. Vyas. (2006). Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 24:5559–5570.
- D. T. O'Hagan. (2001). Recent developments in vaccine delivery systems. Curr. Drug Targets Infect. Disord. 1:273–286.
- S. Patil, A. J. Khopade, S. Nagaich, G. P. Agrawal, and N. K. Jain. (1999). Adsorption studies of sugars on calcium hydroxy apatite ceramics and hemoglobin on sugar-coated ceramics. Pharmazie. 54 (4):310–312.
- J. Rexroad, C. M. Wiethoff, L. S. C. Jones, and R. Middaugh. (2002). Lyophilization and the thermostability of vaccines. Cell Preserv. Technol. 1 (2):91–104.
- M. Saifuddin, M. L. Hart, H. Gewurz, Y. Zhang, and G. T. Spear. (2000). Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 81:949–955.
- L. L. So, and I. J. Goldstein. (1967). Application of the quantitative precipitin method to polysaccharide-concanavalin A interaction. J. Biol. Chem. 242:1617–1622.
- A. C. Tas. (2001). X-ray diffraction data for flux grown calcium hydroxyapatite whiskers. Powder Diffr. 16 (2):102–106.